CELU - Celularity Inc
Previous close
2.15
0 0%
Share volume: 2,015
Last Updated: Thu 26 Dec 2024 08:15:44 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.15
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
Report Date | 2022-05-16 | 2022-08-09 | 2022-11-10 | 2023-03-31 | 2023-05-22 | 2023-08-14 | 2024-01-03 | 2024-07-30 | |
Total revenue | 5.935 M | 3.776 M | 4.135 M | 4.129 M | 3.935 M | 2.938 M | 3.786 M | 12.112 M | |
Cost of revenue | 4.026 M | 3.179 M | 7.213 M | 5.247 M | 2.003 M | 802.000 K | 3.602 M | 9.609 M | |
Gross profit | 1.909 M | 597.000 K | -3.078 M | -1.118 M | 1.932 M | 2.136 M | 184.000 K | 2.503 M | |
-68.73% | -615.58% | 63.68% | 272.81% | 10.56% | -91.39% | 1,260.33% | |||
Operating expenses | 38.133 M | 40.923 M | 35.258 M | 30.070 M | 30.885 M | 21.430 M | 15.930 M | 12.796 M | |
Selling general and admin | 16.460 M | 15.574 M | 14.907 M | 19.080 M | 13.934 M | 12.826 M | 10.748 M | 13.068 M | |
Research and development | 21.673 M | 25.349 M | 20.351 M | 10.990 M | 16.951 M | 8.604 M | 5.182 M | -272.000 K | |
Total expenses | 42.700 M | 44.648 M | 43.024 M | 35.870 M | 57.104 M | 23.021 M | 20.328 M | -1.203 M | |
4.56% | -3.64% | -16.63% | 59.20% | -59.69% | -11.70% | -105.92% | |||
Operating income | -36.765 M | -40.872 M | -38.889 M | -31.741 M | -53.169 M | -20.083 M | -16.542 M | 13.315 M | |
Ebit | -36.765 M | -40.872 M | -38.889 M | -31.741 M | -53.169 M | -20.083 M | -16.542 M | 13.315 M | |
Pretax income | -62.867 M | 47.843 M | 4.782 M | 24.447 M | -64.017 M | -47.949 M | -93.876 M | 9.557 M | |
-176.10% | -90.00% | 411.23% | -361.86% | -25.10% | 95.78% | -110.18% | |||
Income tax | 0.000 | 17.000 K | -17.000 K | 13.000 K | 0.000 | 0.000 | 0.000 | 10.000 K | |
Net income basic | -62.867 M | 47.826 M | 4.799 M | 24.434 M | -64.017 M | -47.949 M | -93.876 M | 9.547 M | |
176.07% | -89.97% | 409.15% | -362.00% | 25.10% | -95.78% | 110.17% | |||
Net income | -62.867 M | 47.826 M | 4.799 M | 24.434 M | -64.017 M | -47.949 M | -93.876 M | 9.547 M | |
176.07% | -89.97% | 409.15% | -362.00% | 25.10% | -95.78% | 110.17% |